References

• Abdo-Rabbo, A., Haaijer-Ruskamp, F., & Basharahil, K. (2000). Baseline prescribing and health facility indicators in Yemen. J Fac Med Baghdad, 42(4), 824-829.
• Akl, O. A., El Mahalli, A. A., Elkahky, A. A., & Salem, A. M. (2014). WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. Journal of Taibah University Medical Sciences, 9(1), 54-64.
• Angamo, M. T., Wabe, N. T., & Raju, N. (2011). Assessment of patterns of drug use by using World Health Organization's prescribing, patient care and health facility indicators in selected health facilities in Southwest Ethiopia.
• Asghar, M., Mumtaz, N., Niaz, S., Zaheer, K., & Raza, M. (2017). Prescribing behaviour of practitioners in public and private hospitals in Pakistan evaluated using the World Health Organization (WHO) indicators: A comparative approach. Le Pharmacien Hospitalier et Clinicien, 52(3), 299-305.
• Atif, M., Azeem, M., Sarwar, M. R., Malik, I., Ahmad, W., Hassan, F., . . . Rana, M. (2018). Evaluation of prescription errors and prescribing indicators in the private practices in Bahawalpur, Pakistan. Journal of the Chinese Medical Association, 81(5), 444-449.
• Atif, M., Azeem, M., Sarwar, M. R., Shahid, S., Javaid, S., Ikram, H., . . . Scahill, S. (2016). WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan. Springerplus, 5(1), 1-7.
• Atif, M., Sarwar, M. R., Azeem, M., Umer, D., Rauf, A., Rasool, A., . . . Scahill, S. (2016). Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan. Journal of pharmaceutical policy and practice, 9(1), 1-8.
• Basger, B. J., Chen, T. F., & Moles, R. J. (2008). Inappropriate medication use and prescribing indicators in elderly Australians. Drugs & aging, 25(9), 777-793.
• Bhat, D., Koonisetty, K., & Saraswathy, G. (2018). Periodic Supervision of Drug Prescribing and Rational Drug use Among Anemic Patients of a Developing Nation Using who Prescribing Indicators. Value in Health, 21, S112.
• Chandelkar, U., & Rataboli, P. (2014). A study of drug prescribing pattern using WHO prescribing indicators in the state of Goa, India. Int J Basic Clin Pharmacol, 3(6), 1057-1061.
• Desalegn, A. A. (2013). Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC health services research, 13(1), 1-6.
• Dong, L., Yan, H., & Wang, D. (2011). Drug prescribing indicators in village health clinics across 10 provinces of Western China. Family practice, 28(1), 63-67.
• El Mahalli, A. (2012). WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. EMHJ-Eastern Mediterranean Health Journal, 18 (11), 1091- 1096, 2012.
• Ferreira, M. B. C., Heineck, I., Flores, L. M., Camargo, A. L., Dal Pizzol, T. d. S., Torres, I. L. d. S., . . . Cardoso, T. F. M. (2013). Rational use of medicines: prescribing indicators at different levels of health care. Brazilian Journal of Pharmaceutical Sciences, 49(2), 329-340.
• Ghei, P. (1995). How to investigate drug use in health facilities. Selected drug use indicators: WHO publications, Geneva, 87 pp., 1993. Health Policy, 34(1), 73-71.
• Gostin, L. O. (1998). The Epidemics of Injecting Drug Use and Blood-Borne Disease: A Public Health Perspective. Specialty law digest. Health care law(231), 9-40.
• James, H., Handu, S. S., Al Khaja, K. A., Otoom, S., & Sequeira, R. P. (2006). Evaluation of the knowledge, attitude and practice of self- medication among first-year medical students. Medical principles and practice, 15(4), 270-275.
• Lenjisa, J. L., & Fereja, T. H. (2014). A retrospective analysis of prescribing practices through WHO prescribing indicators at four selected hospitals of West Ethiopia. J Bioanal Biomed, 6(2), 29.
• McColl, A., Roderick, P., & Gabbay, J. (1997). 1 Secretary of State for Health. The new NHS. London: Stationery Office, 1997. 2 NHS Executive. The new NHS, modern and dependable: a national framework for assessing performance. London: Department of Health, 1998. 3 Secretary of State for Health. Our healthier nation. London: Stationery. Institute for Health Research and Development, 167, 88.
• Mousavi, S., Roien, R., & Ramozi, A. (2018). Evaluation of antibiotic prescribing in Kabul, Afghanistan. European journal of internal medicine, 55, e13-e15.
• Ofori-Asenso, R. (2016). A closer look at the World Health Organization's prescribing indicators. Journal of pharmacology & pharmacotherapeutics, 7(1), 51.
• Ofori-Asenso, R., Brhlikova, P., & Pollock, A. M. (2016). Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC public health, 16(1), 1-14.
• Organization, W. H. (1993). How to investigate drug use in health facilities: selected drug use indicators.
• Pradhan, M., & Mathur, M. (2016). Evaluation of prescribing indicators and pattern among dermatological outpatients in a teaching hospital of central Nepal. Journal of College of Medical Sciences-Nepal, 12(2), 44-49.
• Prakash, B., Nadig, P., & Nayak, A. (2016). Rational prescription for a dermatologist. Indian journal of dermatology, 61(1), 32.
• Tsega, B., & Makonnen, E. (2012). Comparative evaluation of drug prescription appropriateness in public and private health institutions of South West Ethiopia: the case of Wolkite town. International Journal of Pharmaceutical Sciences and Research, 3(12), 4922.
• Van der Geest, S., Hardon, A., & Whyte, S. R. (1990). Policy issue. Health Policy and Planning, 5(2), 182-185.
• Yin, X., Song, F., Gong, Y., Tu, X., Wang, Y., Cao, S., . . . Lu, Z. (2013). A systematic review of antibiotic utilization in China. Journal of antimicrobial Chemotherapy, 68(11), 2445-2452.
• Yuniar, Y., Susyanty, A. L., & Sari, I. D. (2017). Assessment of Prescribing Indicators in Public and Private Primary Health Care Facilities in Java, Indonesia. Indonesian Pharmaceutical Journal, 7(1), 55-66.